• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Multiplex assay for subtyping avian influenza A viruses by cDNA hybridization and adapter-mediated amplification

tetano

Editor, Senior Moderator
Appl Microbiol Biotechnol. 2016 Jul 2. [Epub ahead of print]
[h=1]Multiplex assay for subtyping avian influenza A viruses by cDNA hybridization and adapter-mediated amplification.[/h] Yang G[SUP]1[/SUP], Jones J[SUP]1[/SUP], Jang Y[SUP]1[/SUP], Davis CT[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Multiple subtypes of influenza A viruses circulating in animals must be closely monitored to understand their risk to humans and animal populations. Many molecular-based subtyping methods require constant monitoring of viral genomes for primer and/or probe mismatches and are prone to primer-primer interactions. This report presents a new approach that involves target enrichment through cDNA hybridization followed by adapter-mediated amplification for subtyping influenza virus (AmASIV). As a proof of concept, the AmASIV assay was multiplexed to specifically detect and differentiate influenza A virus subtypes (H5, N5, N7, and N9) in a single reaction without cross-recognition of nontarget subtypes or influenza B virus. The limit of detection (LOD) of AmASIV, as measured by 50 % egg-infective dose per reaction (EID[SUB]50[/SUB]/reaction), was comparable to that of singleplex TaqMan? qPCR assays with LODs of 10[SUP]-0.6[/SUP] (H5), 10[SUP]2[/SUP] (N5), 10[SUP]-0.3[/SUP] (N7), and 10[SUP]-0.5[/SUP] (N9) EID[SUB]50[/SUB]/reaction. The AmASIV will strengthen animal influenza virus surveillance and laboratory capacity to improve prevention and control of influenza.


[h=4]KEYWORDS:[/h] AmASIV; Influenza; Subtyping; Surveillance

PMID: 27372075 DOI: 10.1007/s00253-016-7664-8
[PubMed - as supplied by publisher]
 
Back
Top Bottom